Antara Barua, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barua’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A154164 · Current
Licensed to practise in California · since 2018 · expires 2027-10-31 · Chittagong University, Comilla Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$659,788 in 2024
Medicaid paid $659,788 for 14,823 billed services this clinician did in 2024, up to 153 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,179 | $603,876 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 102 | $45,845 |
| Short return visit (20+ min) | 2,240 | $3,586 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 69 | $1,905 |
| Blood test, lipids (cholesterol and triglycerides) | 248 | $663 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 87 | $607 |
| Return visit (30+ min) | 209 | $526 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 84 | $447 |
| Thyroid stimulating hormone (TSH) | 227 | $426 |
| HEPATITIS C ANTIBODY | 91 | $366 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 42 | $290 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 17 | $272 |
| 2024 | 14,823 | 44 | 153 | $659,788 |
| 2023 | 7,119 | 37 | 121 | $555,516 |
| 2022 | 6,522 | 27 | 120 | $541,807 |
| 2021 | 2,974 | 16 | 93 | $468,875 |
| 2020 | 1,964 | 5 | 67 | $256,320 |
| 2019 | 918 | 3 | 80 | $137,192 |
| 2018 | 297 | 4 | 103 | $49,821 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,111 | $548,589 |
| Short return visit (20+ min) | 2,038 | $3,743 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 113 | $741 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 126 | $496 |
| Blood test, lipids (cholesterol and triglycerides) | 221 | $294 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 41 | $204 |
| Hemoglobin A1C level | 291 | $191 |
| HEPATITIS C ANTIBODY | 117 | $190 |
| Return visit (30+ min) | 76 | $189 |
| Thyroid stimulating hormone (TSH) | 99 | $179 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 512 | $176 |
| COMPREHENSIVE METABOLIC PANEL | 137 | $131 |
2022
| Clinic visit/encounter, all-inclusive | 1,121 | $539,216 |
| Short return visit (20+ min) | 1,723 | $1,210 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 21 | $231 |
| Short return visit | 454 | $199 |
| Blood test, lipids (cholesterol and triglycerides) | 266 | $145 |
| Hemoglobin A1C level | 342 | $133 |
| Thyroid stimulating hormone (TSH) | 137 | $121 |
| HEPATITIS C ANTIBODY | 117 | $94 |
| COMPREHENSIVE METABOLIC PANEL | 192 | $90 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 46 | $88 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 93 | $80 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 301 | $71 |
2021
| Clinic visit/encounter, all-inclusive | 988 | $466,904 |
| Short return visit | 915 | $984 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 13 | $520 |
| Short return visit (20+ min) | 582 | $433 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 67 | $27 |
| Hemoglobin A1C level | 62 | $7 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 35 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 46 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 12 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 14 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 91 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 41 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 785 | $254,792 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 177 | $648 |
| Short return visit (20+ min) | 397 | $503 |
| Short return visit | 472 | $377 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 133 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 422 | $135,897 |
| Short return visit (20+ min) | 475 | $1,237 |
| Short return visit | 21 | $59 |
2018
| Clinic visit/encounter, all-inclusive | 161 | $49,821 |
| Short return visit | 31 | $0 |
| Short return visit (20+ min) | 93 | $0 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 12 | $0 |
Drugs they prescribed that Part D paid
$274,660
Pharmacies billed $274,660 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (62 of 2,365) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,949 generic and 386 brand-name prescriptions · $274,660 in drug cost · 15 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 51 | $55,538 | $1,089 |
| Jardiance | 38 | $46,799 | $1,232 |
| Trulicity | 26 | $25,443 | $979 |
| Rybelsus | 13 | $20,492 | $1,576 |
| Ozempic | 20 | $17,954 | $898 |
See all 52 drugs
| Mounjaro | 51 | $55,538 | $1,089 |
| Jardiance | 38 | $46,799 | $1,232 |
| Trulicity | 26 | $25,443 | $979 |
| Rybelsus | 13 | $20,492 | $1,576 |
| Ozempic | 20 | $17,954 | $898 |
| Eliquis | 12 | $11,606 | $967 |
| Spiriva Respimat | 22 | $11,087 | $504 |
| Xarelto | 11 | $10,907 | $992 |
| Semglee (Yfgn) | 18 | $7,454 | $414 |
| Insulin Aspart Flexpen | 19 | $4,766 | $251 |
| Ultra-Fine Nano Pen Needle | 15 | $1,699 | $113 |
| Albuterol Sulfate Hfa | 35 | $1,184 | $34 |
| Atorvastatin | 188 | $968 | $5 |
| Fosinopril | 35 | $749 | $21 |
| Metformin | 131 | $626 | $5 |
| Levothyroxine | 80 | $622 | $8 |
| Tamsulosin | 79 | $532 | $7 |
| Gabapentin | 64 | $490 | $8 |
| Amlodipine Besylate | 136 | $485 | $4 |
| Metoprolol | 28 | $396 | $14 |
| Losartan | 76 | $374 | $5 |
| Fluticasone Propionate | 54 | $374 | $7 |
| Omeprazole | 77 | $352 | $5 |
| Baclofen | 32 | $293 | $9 |
| Lisinopril | 68 | $255 | $4 |
| Propranolol | 16 | $250 | $16 |
| Hydrochlorothiazide | 106 | $235 | $2 |
| Metoprolol | 56 | $217 | $4 |
| Glipizide | 43 | $217 | $5 |
| Hydrocodone-Acetaminophen | 27 | $210 | $8 |
| Benazepril | 18 | $191 | $11 |
| Simvastatin | 32 | $152 | $5 |
| Furosemide | 22 | $151 | $7 |
| Glipizide Er | 12 | $146 | $12 |
| Pravastatin | 14 | $144 | $10 |
| Diltiazem 24hr Er (Cd) | 14 | $143 | $10 |
| Clopidogrel | 18 | $133 | $7 |
| Atenolol | 26 | $129 | $5 |
| Mirtazapine | 20 | $128 | $6 |
| Oxycodone-Acetaminophen | 13 | $127 | $10 |
| Famotidine | 20 | $115 | $6 |
| Bupropion Hcl Sr | 12 | $109 | $9 |
| Sertraline | 27 | $104 | $4 |
| Ibuprofen | 31 | $101 | $3 |
| Acetaminophen-Codeine | 12 | $98 | $8 |
| Trazodone | 18 | $95 | $5 |
| Alendronate | 13 | $77 | $6 |
| Metformin Hcl Er | 13 | $70 | $5 |
| Carvedilol | 14 | $69 | $5 |
| Fluoxetine | 15 | $59 | $4 |
| Pantoprazole | 17 | $57 | $3 |
| Meloxicam | 15 | $30 | $2 |
Year by year
| 2024 | 2,365 | 186 | 3% (62) | 16% | $274,660 |
| 2023 | 1,877 | 198 | 2% (43) | 17% | $243,433 |
| 2022 | 1,698 | 207 | 5% (80) | 17% | $198,155 |
| 2021 | 789 | 268 | 4% (30) | None | $45,336 |
| 2020 | 732 | 319 | 7% (52) | None | $61,076 |
| 2019 | 466 | 247 | 9% (43) | 16% | $25,809 |
| 2018 | 79 | 52 | None | 22% | $3,005 |
| 2016 | 78 | 24 | None | 19% | $4,464 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Trulicity | 32 | $32,234 | $1,007 |
| Ozempic | 26 | $30,206 | $1,162 |
| Jardiance | 28 | $29,314 | $1,047 |
| Mounjaro | 13 | $13,374 | $1,029 |
| Spiriva Respimat | 22 | $10,829 | $492 |
| Novolog Flexpen | 14 | $8,727 | $623 |
| Advair Diskus | 14 | $6,199 | $443 |
| Atorvastatin | 147 | $3,239 | $22 |
| Metformin | 104 | $1,597 | $15 |
| Tamsulosin | 57 | $1,153 | $20 |
| Amlodipine Besylate | 96 | $1,142 | $12 |
| Ventolin Hfa | 19 | $1,120 | $59 |
| Simvastatin | 43 | $1,071 | $25 |
| Losartan | 58 | $1,034 | $18 |
| Albuterol Sulfate Hfa | 20 | $985 | $49 |
| Gabapentin | 40 | $938 | $23 |
| Levothyroxine | 64 | $898 | $14 |
| Omeprazole | 66 | $795 | $12 |
| Lisinopril | 48 | $738 | $15 |
| Baclofen | 26 | $658 | $25 |
| Metoprolol | 44 | $639 | $15 |
| Fosinopril | 25 | $612 | $24 |
| Diclofenac | 24 | $612 | $25 |
| Metoprolol | 25 | $546 | $22 |
| Fluticasone Propionate | 45 | $516 | $11 |
| Carvedilol | 21 | $428 | $20 |
| Glipizide | 28 | $409 | $15 |
| Furosemide | 30 | $403 | $13 |
| Atenolol | 34 | $345 | $10 |
| Sertraline | 17 | $332 | $20 |
| Montelukast | 11 | $277 | $25 |
| Metformin Hcl Er | 17 | $272 | $16 |
| Benazepril | 12 | $246 | $20 |
| Hydrochlorothiazide | 67 | $234 | $3 |
| Hydrocodone-Acetaminophen | 23 | $227 | $10 |
| Propranolol | 12 | $223 | $19 |
| Famotidine | 21 | $181 | $9 |
| Mirtazapine | 20 | $149 | $7 |
| Bupropion Hcl Sr | 12 | $123 | $10 |
| Ibuprofen | 29 | $122 | $4 |
| Trazodone | 11 | $110 | $10 |
| Fluoxetine | 12 | $78 | $6 |
| Meloxicam | 15 | $46 | $3 |
2022: 44 drugs
| Trulicity | 33 | $28,924 | $876 |
| Jardiance | 21 | $18,114 | $863 |
| Spiriva Respimat | 25 | $12,043 | $482 |
| Lantus Solostar | 16 | $9,657 | $604 |
| Novolog Flexpen | 11 | $8,648 | $786 |
| Advair Diskus | 14 | $5,362 | $383 |
| Atorvastatin | 93 | $1,603 | $17 |
| Baclofen | 39 | $986 | $25 |
| Amlodipine Besylate | 100 | $963 | $10 |
| Levothyroxine | 58 | $820 | $14 |
| Gabapentin | 43 | $689 | $16 |
| Metoprolol | 21 | $642 | $31 |
| Albuterol Sulfate Hfa | 13 | $601 | $46 |
| Omeprazole | 72 | $596 | $8 |
| Hydrocodone-Acetaminophen | 55 | $549 | $10 |
| Losartan | 33 | $429 | $13 |
| Carvedilol | 24 | $411 | $17 |
| Diclofenac | 12 | $388 | $32 |
| Metformin | 50 | $385 | $8 |
| Fosinopril | 22 | $382 | $17 |
| Metoprolol | 42 | $380 | $9 |
| Atenolol | 24 | $345 | $14 |
| Lisinopril | 40 | $338 | $8 |
| Tamsulosin | 32 | $312 | $10 |
| Oxycodone-Acetaminophen | 11 | $308 | $28 |
| Fluticasone Propionate | 39 | $307 | $8 |
| Simvastatin | 43 | $300 | $7 |
| Loperamide | 16 | $250 | $16 |
| Hydrochlorothiazide | 51 | $228 | $4 |
| Glipizide | 27 | $224 | $8 |
| Furosemide | 21 | $214 | $10 |
| Benazepril | 14 | $167 | $12 |
| Triamcinolone Acetonide | 16 | $167 | $10 |
| Glipizide Xl | 11 | $153 | $14 |
| Trazodone | 20 | $146 | $7 |
| Bupropion Hcl Sr | 12 | $144 | $12 |
| Montelukast | 13 | $137 | $11 |
| Clopidogrel | 11 | $136 | $12 |
| Mirtazapine | 17 | $135 | $8 |
| Ibuprofen | 25 | $106 | $4 |
| Metformin Hcl Er | 13 | $80 | $6 |
| Acetaminophen-Codeine | 12 | $76 | $6 |
| Meloxicam | 17 | $62 | $4 |
| Naproxen | 17 | $40 | $2 |
2021: 20 drugs
| Atorvastatin | 51 | $738 | $14 |
| Levothyroxine | 29 | $608 | $21 |
| Metoprolol | 14 | $424 | $30 |
| Omeprazole | 43 | $396 | $9 |
| Amlodipine Besylate | 52 | $333 | $6 |
| Baclofen | 16 | $281 | $18 |
| Losartan | 21 | $277 | $13 |
| Gabapentin | 22 | $190 | $9 |
| Fluticasone Propionate | 17 | $143 | $8 |
| Metformin | 22 | $135 | $6 |
| Tamsulosin | 19 | $134 | $7 |
| Atenolol | 16 | $131 | $8 |
| Furosemide | 26 | $130 | $5 |
| Hydrochlorothiazide | 27 | $114 | $4 |
| Hydrocodone-Acetaminophen | 11 | $111 | $10 |
| Allopurinol | 11 | $107 | $10 |
| Metoprolol | 17 | $102 | $6 |
| Lisinopril | 19 | $101 | $5 |
| Ibuprofen | 14 | $76 | $5 |
| Simvastatin | 12 | $51 | $4 |
2020: 19 drugs
| Myrbetriq | 12 | $8,139 | $678 |
| Levothyroxine | 34 | $827 | $24 |
| Hydrocodone-Acetaminophen | 23 | $576 | $25 |
| Atorvastatin | 28 | $453 | $16 |
| Gabapentin | 26 | $453 | $17 |
| Amitriptyline | 14 | $440 | $31 |
| Fosinopril | 16 | $242 | $15 |
| Metformin | 19 | $155 | $8 |
| Omeprazole | 19 | $148 | $8 |
| Fluticasone Propionate | 16 | $145 | $9 |
| Lisinopril | 15 | $142 | $9 |
| Losartan | 11 | $140 | $13 |
| Amlodipine Besylate | 31 | $140 | $5 |
| Alendronate | 12 | $108 | $9 |
| Trazodone | 14 | $83 | $6 |
| Metoprolol | 12 | $63 | $5 |
| Furosemide | 12 | $52 | $4 |
| Ibuprofen | 15 | $51 | $3 |
| Hydrochlorothiazide | 15 | $50 | $3 |
2019: 6 drugs
| Oseltamivir Phosphate | 11 | $845 | $77 |
| Hydrocodone-Acetaminophen | 19 | $367 | $19 |
| Baclofen | 11 | $107 | $10 |
| Lisinopril | 14 | $104 | $7 |
| Amlodipine Besylate | 11 | $68 | $6 |
| Furosemide | 12 | $37 | $3 |
Professional record
- NPI
- 1841686334
- Licence
- CA A154164California A154164: Current · expires 2027-10-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 367 Santana Hts Unit 4039, San Jose, CA, 95128
- NPI first listed
- 2015-04-10
- NPI last updated
- 2019-04-26
This is when the NPI record was last certified, not a medical board exam.